Rare lephants
Screener

MapLight Therapeutics, Inc.

MPLT ·Healthcare, Drug Manufacturers - General, United States
Price Ratios › P/S (Price-to-Sales)
← 5Y 10Y MAX →

P/S (Price-to-Sales) isn’t available yet

Not enough data to compute P/S (Price-to-Sales) for MPLT right now — this needs at least four trailing quarters of filings data plus a nearby quarterly price in etc/price_data/MPLT.csv for each point. Other charts on this site don't depend on it and are unaffected.